Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Article CAS PubMed Google Scholar
van der Veen A, Brenkman HJF, Seesing MFJ, Haverkamp L, Luyer MDP, Nieuwenhuijzen GAP, et al. Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial. J Clin Oncol. 2021;39(9):978–89.
Haverkamp L, Brenkman HJ, Seesing MF, Gisbertz SS, van Berge Henegouwen MI, Luyer MD, et al. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). BMC Cancer. 2015;15:556. https://doi.org/10.1186/s12885-015-1551-z.
Article PubMed PubMed Central Google Scholar
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.
Article CAS PubMed Google Scholar
Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet (London, England). 2019;393(10184):1948–57.
Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715–21. https://doi.org/10.1200/jco.2010.33.0597.
Article CAS PubMed Google Scholar
Coccolini F, Nardi M, Montori G, Ceresoli M, Celotti A, Cascinu S, et al. Neoadjuvant chemotherapy in advanced gastric and esophago gastric cancer Meta analysis of randomized trials. Int J Surg. 2018. https://doi.org/10.1016/j.ijsu.2018.01.008.
Joharatnam-Hogan N, Shiu KK, Khan K. Challenges in the treatment of gastric cancer in the older patient. Cancer Treatment Rev. 2020;85:101980. https://doi.org/10.1016/j.ctrv.2020.101980.
Wu C, Wang N, Zhou H, Wang T, Mao Q, Zhang X, et al. Effects of Neoadjuvant Chemotherapy Toxicity and Postoperative Complications on Short-term and Long-term Outcomes After Curative Resection of Gastric Cancer. J Gastrointest Surg. 2020;24(6):1278–89.
Robb WB, Messager M, Goere D, Pichot-Delahaye V, Lefevre JH, Louis D, et al. Predictive factors of postoperative mortality after junctional and gastric adenocarcinoma resection. JAMA Surg. 2013;148(7):624–31.
Robb WB, Messager M, Gronnier C, Tessier W, Hec F, Piessen G, et al. High-Grade Toxicity to Neoadjuvant Treatment for Upper Gastrointestinal Carcinomas: What is the Impact on Perioperative and Oncologic Outcomes? Ann Surg Oncol. 2015;22(11):3632–9.
Busweiler LA, Wijnhoven BP, van Berge Henegouwen MI, Henneman D, van Grieken NC, Wouters MW, et al. Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit. Br J Surg. 2016;103(13):1855–63.
Article CAS PubMed Google Scholar
Voeten DM, Busweiler LAD, van der Werf LR, Wijnhoven BPL, Verhoeven RHA, van Sandick JW, et al. Outcomes of Esophagogastric Cancer Surgery During Eight Years of Surgical Auditing by the Dutch Upper Gastrointestinal Cancer Audit (DUCA). Ann Surg. 2021;274(5):866–73.
Borggreve AS, Kingma BF, Ruurda JP, van Hillegersberg R, Dutch Upper GICA. Safety and feasibility of minimally invasive surgical interventions for esophageal and gastric cancer in the acute setting: a nationwide cohort study. Surg Endoscopy. 2021;35(3):1219–29.
Wu Z, Yan S, Liu Z, Jing C, Liu F, Yu J, et al. Postoperative abdominal complications of gastric and colorectal cancer surgeries in China: a multicentered prospective registry-based cohort study. Science bulletin. 2022;67(24):2517–21.
van der Werf LR, Voeten SC, van Loe CMM, Karthaus EG, Wouters M, Prins HA. Data verification of nationwide clinical quality registries. BJS open. 2019;3(6):857–64.
Article PubMed PubMed Central Google Scholar
Wang JP, E MG, M RV, M DPL, J PR, van Hillegersberg R. Scientific and rigorous data registration of patients with gastric cancer is the cornerstone of high-quality surgical research on gastric cancer: lessons learned from the Dutch upper gastrointestinal cancer audit (DUCA). Chin J Gastrointest Surg. 2023;26(2):148–53.
Wang Q, Wu ZQ, Liu ZN, Li ZY, Ji JF. Establishment and data quality control of a multicenter prospective database for prevalence of abdominal complications after gastroenterological surgery. Chin J Gastrointest Surg. 2023;26(2):154–9.
Cai Y, Song W, Li J, Jing Y, Liang C, Zhang L, et al. The landscape of aging. Science China Life sciences. 2022;65(12):2354–454.
Article PubMed PubMed Central Google Scholar
Tu RH, Lin JX, Xie JW, Wang JB, Lu J, Chen QY, et al. Assessment of the short-term outcomes of laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: A prospective single-armed clinical trial. Surgery. 2022;172(1):160–8.
Terashima M, Iwasaki Y, Mizusawa J, Katayama H, Nakamura K, Katai H, et al. Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501). Gastric Cancer. 2019;22(5):1044–52.
Article CAS PubMed Google Scholar
Liao Y, Yang ZL, Peng JS, Xiang J, Wang JP. Neoadjuvant chemotherapy for gastric cancer: a meta-analysis of randomized, controlled trials. J Gastroenterol Hepatol. 2013;28(5):777–82.
Wang X, Zhao DB, Yang L, Chi Y, Zhao H, Jiang LM, et al. Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized Study. Front Oncol. 2022;12:870741.
Article PubMed PubMed Central Google Scholar
Keywani K, Borgstein ABJ, Eshuis WJ, Pape M, Versteeg KS, Derks S, et al. Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study. Gastric Cancer. 2023;26(5):763–74.
留言 (0)